A detailed history of Price T Rowe Associates Inc transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 8,273 shares of SLP stock, worth $264,818. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,273
Previous 10,048 17.67%
Holding current value
$264,818
Previous $414,000 2.66%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$38.46 - $50.95 $68,266 - $90,436
-1,775 Reduced 17.67%
8,273 $403,000
Q1 2024

May 15, 2024

BUY
$37.48 - $44.74 $21,063 - $25,143
562 Added 5.92%
10,048 $414,000
Q4 2023

Feb 14, 2024

BUY
$33.36 - $45.71 $46,603 - $63,856
1,397 Added 17.27%
9,486 $425,000
Q3 2023

Nov 14, 2023

SELL
$40.03 - $51.51 $44,673 - $57,485
-1,116 Reduced 12.12%
8,089 $338,000
Q2 2023

Aug 14, 2023

BUY
$40.45 - $48.0 $40,166 - $47,664
993 Added 12.09%
9,205 $399,000
Q1 2023

May 15, 2023

BUY
$34.96 - $43.94 $34,120 - $42,885
976 Added 13.49%
8,212 $361,000
Q4 2022

Feb 14, 2023

SELL
$36.55 - $51.15 $94,079 - $131,660
-2,574 Reduced 26.24%
7,236 $265,000
Q3 2022

Nov 14, 2022

SELL
$47.75 - $66.88 $56,010 - $78,450
-1,173 Reduced 10.68%
9,810 $477,000
Q2 2022

Aug 15, 2022

SELL
$40.55 - $51.76 $79,842 - $101,915
-1,969 Reduced 15.2%
10,983 $542,000
Q1 2022

May 16, 2022

BUY
$36.56 - $50.98 $47,418 - $66,121
1,297 Added 11.13%
12,952 $660,000
Q4 2021

Feb 14, 2022

SELL
$37.1 - $57.45 $157,526 - $243,932
-4,246 Reduced 26.7%
11,655 $551,000
Q3 2021

Nov 15, 2021

SELL
$38.45 - $55.66 $2,268 - $3,283
-59 Reduced 0.37%
15,901 $628,000
Q2 2021

Aug 16, 2021

BUY
$49.67 - $68.96 $117,817 - $163,573
2,372 Added 17.46%
15,960 $876,000
Q1 2021

May 17, 2021

BUY
$60.06 - $89.52 $6,846 - $10,205
114 Added 0.85%
13,588 $859,000
Q4 2020

Feb 16, 2021

BUY
$53.26 - $77.18 $717,625 - $1.04 Million
13,474 New
13,474 $969,000

Others Institutions Holding SLP

About Simulations Plus, Inc.


  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $650M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.